4.6 Article

The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia

期刊

ATHEROSCLEROSIS
卷 358, 期 -, 页码 41-46

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2022.08.014

关键词

Familial hypercholesterolemia; Variant; LDLR; PCSK9; Thickness of the Achilles tendon; Softness of the Achilles tendon; Ultrasonography

资金

  1. Ministry of Health, Labor and Welfare of Japan for Clinical Research on Intractable Diseases [H30-nanji-ippan-003]
  2. JSPS KAKENHI [JP 20H01112]
  3. Terumo Life Science Foundation
  4. Japanese Circulation Society

向作者/读者索取更多资源

This study found a significant correlation between LDLR gene variants and AT thickness and softness, while PCSK9 gene variants were not associated. Evaluating AT is important for identifying FH patients with LDLR gene variants at high risk for CAD.
Background and aims: Familial hypercholesterolemia (FH) is characterized by high low-density lipoprotein (LDL)-cholesterol, xanthoma of the Achilles tendon (AT), and premature coronary artery disease (CAD). Ultrasonography can assess AT thickness and softness, making it useful for evaluating AT in FH diagnosis. We aimed to clarify whether FH-causative LDLR or PCSK9 variants affect AT thickness or softness. Methods: In total, 248 FH and 60 non-familial hypercholesterolemia (non-FH) patients (total: 308) aged >= 30 years were enrolled. Patients with FH were classified according to genotype. AT thickness and elasticity index (EI) as softness were measured by ultrasonography. Results: In FH patients with LDLR variants, AT was significantly thicker and softer than it was in FH patients with PCSK9 variants, FH patients without LDLR or PCSK9 variants, and patients with non-FH. The proportion of patients harboring LDLR variants significantly increased with AT thickness (p = 2.0 x 10(-31)) and softness (p = 1.4 x 10(-18)). Among those with AT thickness>8.5 mm and EI < 3.9, patients with LDLR variants accounted for 89% and 83%, respectively. The odds of AT thickening, AT softening and CAD increased 13.3-fold, 4.9-fold, and 2.1-fold, adjusted for the LDL-C year score by the presence of LDLR variants compared with those of patients without LDLR or PCSK9 variants. PCSK9 variants did not influence AT thickening or softening or CAD prevalence. Conclusions: LDLR variants affected AT thickness and softness independent of the LDL-C year score, but PCSK9 variants did not. Evaluating AT is important for identifying FH patients with LDLR variants at high risk for CAD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据